Krystina Dunston on Using Targeted Therapy to Slow Endometrial Cancer

A novel method may growth of endometrial cancer via through targeted cancer cell therapy.

Using mice models, Krystina Dunston, research lab manager at the University of Missouri School of Medicine and colleagues from NextGen Precision Health studied the use of targeted cancer cell therapy in mice with a PTEN mutation, which normally regulates cell division and growth.

Dunston spoke with DocWire News about the findings, which showed that by targeting and silencing ERBB2 gene expression, the chances of stopping tumor growth significantly increased.